Table 2.
HC versus AD | HC versus MCI | MCI versus AD | ||
---|---|---|---|---|
GNP | AUC (±95% CI) | 0.99 (0.99–1.0) | 0.94 (0.92–0.96) | 0.81 (0.78–0.85) |
Sensitivity/Specificity | 0.98/0.96 | 0.85/0.88 | 0.71/0.76 | |
Youden Index | 0.94 | 0.73 | 0.47 | |
Cutoff# | −0.86 | −0.52 | −1.85 | |
Classification Accuracy | 94% | 85% | 74% | |
WIV | AUC (±95% CI) | 0.96 (0.95–0.98) | 0.89 (0.86–0.91) | 0.72 (0.68–0.76) |
Sensitivity/Specificity | 0.88/0.93 | 0.79/0.83 | 0.64/0.73 | |
Youden Index | 0.81 | 0.62 | 0.37 | |
Cutoff | 1.26 | 1.09 | 1.64 | |
Classification Accuracy | 90% | 80% | 70% | |
GNP+WIV | AUC (±95% CI) | 0.99 (0.99–1.0) | 0.95 (0.94–0.97)* | 0.81 (0.78–0.85) |
Sensitivity/Specificity | 0.98/0.97 | 0.85/0.93 | 0.71/0.76 | |
Youden Index | 0.95 | 0.78 | 0.47 | |
Classification Accuracy | 98% | 94% | 83% |
Bold text indicated the best model for predicting group.
Overall AUC is significantly improved with the addition of a measure of variability (WIV).
GNP Cutoff scores are reported as a Z-score.
AD, Alzheimer’s disease; AUC, area under the curve; CI, confidence interval; GNP, global neuropsychological performance; HC, healthy participants; MCI, mild cognitive impairment; WIV, within-individual variability.